Completed OBSERVATIONAL NCT04665232

Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases

Immunomodulatory Effects of Subcutaneous Progesterone in Patients Undergoing IVF Affected by Autoimmune Diseases

Sponsor: San Carlo Public Hospital, Potenza, Italy

Conditions Autoimmune Diseases Infertility

Interventions aqueous subcutaneous progesterone

Updated 4 times since 2021 Last updated: May 23, 2024 Started: Apr 30, 2014 Primary completion: Apr 30, 2017 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Autoimmune Diseases and Infertility, this trial is completed. The trial is conducted by San Carlo Public Hospital, Potenza, Italy and has accumulated 4 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2024 — Jul 2024 [monthly]

Completed
Jan 2021 — Jun 2024 [monthly]

Completed

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

San Carlo Public Hospital, Potenza, Italy

Data source: San Carlo Public Hospital, Potenza, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Potenza, Italy